Related Experiment Video
Updated: Apr 15, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Multidrug-resistant tuberculosis in the Amazonas State, Brazil, 2000-2011
M da S Garrido1, S Bührer-Sékula2, A B Souza3
1Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Universidade do Estado do Amazonas, Manaus, Amazonas, Brazil; Fundação de Vigilância em Saúde do Amazonas, Manaus, Amazonas, Brazil; Secretaria Municipal de Saúde de Manaus, Manaus, Amazonas, Brazil.
Multidrug-resistant tuberculosis (MDR-TB) poses a significant threat in Amazonas, with 81 cases identified between 2000-2011. Improved resistance investigation is crucial for effective TB control in the region.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Tuberculosis (TB) control in Amazonas faces challenges with nearly 3000 cases annually.
- Multidrug-resistant TB (MDR-TB) threatens the effectiveness of TB control programs.
Purpose of the Study:
- To determine the incidence of MDR-TB cases in Amazonas.
- To refine estimates of the overall TB burden in the region.
Main Methods:
- Data on MDR-TB cases from 2000 to 2011 were extracted from the Brazilian National Mandatory Disease Reporting System (SINAN) and the Brazilian Epidemiological Surveillance System of Multidrug Resistance (TBMR).
Main Results:
- Eighty-one MDR-TB cases were reported.
- Acquired MDR-TB constituted 82.7% of cases, with primary and initial rates at 3.8% and 13.7%, respectively.
- Treatment outcomes showed a 45.7% cure rate and a 25.9% death rate among MDR-TB patients. Contact tracing was insufficient, with only 35% of reported contacts examined.
Conclusions:
- The identified number of MDR-TB cases appears low relative to the high TB prevalence in Amazonas.
- A significant gap exists in patient awareness of TB exposure, with most unaware of contact with infectious individuals.
- The findings underscore the necessity of enhancing resistance surveillance for all TB cases in Amazonas.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Clinical Significance of Antibiotic Resistance

